These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2563287)
1. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog. Kopia GA; Valocik RE J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow. Zhao RR; Wang PH; Zhang WF; Fennell WH Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371 [TBL] [Abstract][Full Text] [Related]
3. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries. Kopia GA; Kopaciewicz LJ; Ruffolo RR J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog. Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644 [TBL] [Abstract][Full Text] [Related]
5. Evidence against a role for dopamine D1 receptors in the myocardium of the pig. Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206 [TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine D1 and dopamine D2 receptor agonists on coronary and peripheral hemodynamics. Zhao RR; Fennell WH; Abel FL Eur J Pharmacol; 1990 Nov; 190(1-2):193-202. PubMed ID: 1981750 [TBL] [Abstract][Full Text] [Related]
7. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207 [TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. Clark KL; Hilditch A; Robertson MJ; Drew GM J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog. Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR Chirality; 1990; 2(4):219-25. PubMed ID: 1982058 [TBL] [Abstract][Full Text] [Related]
10. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
11. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung. Polak MJ; Taylor DA Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367 [TBL] [Abstract][Full Text] [Related]
12. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat? Clark KL; Robertson MJ; Drew GM J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232 [TBL] [Abstract][Full Text] [Related]
13. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb. Lokhandwala MF; Watkins HO; Dlewati A Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555 [TBL] [Abstract][Full Text] [Related]
14. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature. Horn PT; Kohli JD Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707 [TBL] [Abstract][Full Text] [Related]
15. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. Hedge SS; Ricci A; Amenta F; Lokhandwala MF J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743 [TBL] [Abstract][Full Text] [Related]
16. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade. Martin SW; Broadley KJ Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney. Woodman OL; Rechtman MP; Lang WJ Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. Hahn RA; Wardell JR; Sarau HM; Ridley PT J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401 [TBL] [Abstract][Full Text] [Related]
19. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine. Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297 [TBL] [Abstract][Full Text] [Related]
20. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]